AAAAAA

   
Results: 1-15 |
Results: 15
SYNERGISTIC INTERACTIONS OF COMBINATIONS OF TOPOTECAN WITH STANDARD DRUGS IN PRIMARY CULTURES OF HUMAN TUMOR-CELLS FROM PATIENTS
Authors: JONSSON E FRIDBORG H NYGREN P LARSSON R
Citation: E. Jonsson et al., SYNERGISTIC INTERACTIONS OF COMBINATIONS OF TOPOTECAN WITH STANDARD DRUGS IN PRIMARY CULTURES OF HUMAN TUMOR-CELLS FROM PATIENTS, European Journal of Clinical Pharmacology, 54(7), 1998, pp. 509-514
CYTOTOXIC ACTIVITY OF CYCLOSPORINE-A AND [3-KETO-BMT(1)]-[VAL(2)]-CYCLOSPORINE (SDZ-PSC-833) ON TUMOR-CELLS FROM PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
Authors: MARTINSSON P NYGREN P FRIDBORG H NILSSON K KRISTENSEN J LARSSON R
Citation: P. Martinsson et al., CYTOTOXIC ACTIVITY OF CYCLOSPORINE-A AND [3-KETO-BMT(1)]-[VAL(2)]-CYCLOSPORINE (SDZ-PSC-833) ON TUMOR-CELLS FROM PATIENTS WITH HEMATOLOGICAL MALIGNANCIES, European Journal of Clinical Pharmacology, 52(3), 1997, pp. 199-203
DIFFERENTIAL ACTIVITY OF CREMOPHOR EL AND PACLITAXEL IN PATIENTS TUMOR-CELLS AND HUMAN CARCINOMA CELL-LINES IN-VITRO
Authors: CSOKA K DHAR S FRIDBORG H LARSSON R NYGREN P
Citation: K. Csoka et al., DIFFERENTIAL ACTIVITY OF CREMOPHOR EL AND PACLITAXEL IN PATIENTS TUMOR-CELLS AND HUMAN CARCINOMA CELL-LINES IN-VITRO, Cancer, 79(6), 1997, pp. 1225-1233
CYTOTOXIC ACTIVITY OF TOPOTECAN IN HUMAN TUMOR-CELL LINES AND PRIMARYCULTURES OF HUMAN TUMOR-CELLS FROM PATIENTS
Authors: JONSSON E FRIDBORG H CSOKA K DHAR S SUNDSTROM C NYGREN P LARSSON R
Citation: E. Jonsson et al., CYTOTOXIC ACTIVITY OF TOPOTECAN IN HUMAN TUMOR-CELL LINES AND PRIMARYCULTURES OF HUMAN TUMOR-CELLS FROM PATIENTS, British Journal of Cancer, 76(2), 1997, pp. 211-219
CYTOTOXIC ACTIVITY OF CALCEIN ACETOXYMETHYL ESTER (CALCEIN AM) ON PRIMARY CULTURES OF HUMAN HEMATOLOGICAL AND SOLID TUMORS/
Authors: JONSSON B LIMINGA G CSOKA K FRIDBORG H DHAR S NYGREN P LARSSON R
Citation: B. Jonsson et al., CYTOTOXIC ACTIVITY OF CALCEIN ACETOXYMETHYL ESTER (CALCEIN AM) ON PRIMARY CULTURES OF HUMAN HEMATOLOGICAL AND SOLID TUMORS/, European journal of cancer, 32A(5), 1996, pp. 883-887
CORRELATION BETWEEN SENSITIVITY IN-VITRO OF PATIENT CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS AND CLINICAL SYSTEMIC EXPOSURE AT THE MAXIMUM TOLERATED DOSE FOR CELL-CYCLE PHASE-SPECIFIC (TYPE-2) ANTICANCER DRUGS
Authors: FRIDBORG H NYGREN N LARSSON R
Citation: H. Fridborg et al., CORRELATION BETWEEN SENSITIVITY IN-VITRO OF PATIENT CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS AND CLINICAL SYSTEMIC EXPOSURE AT THE MAXIMUM TOLERATED DOSE FOR CELL-CYCLE PHASE-SPECIFIC (TYPE-2) ANTICANCER DRUGS, Anti-cancer drugs, 7(1), 1996, pp. 105-108
RELATIONSHIP BETWEEN PHARMACOKINETIC PARAMETERS IN PATIENTS AND CYTOTOXICITY IN-VITRO OF STANDARD AND INVESTIGATIONAL ANTICANCER DRUGS
Authors: FRIDBORG H NYGREN P LARSSON R
Citation: H. Fridborg et al., RELATIONSHIP BETWEEN PHARMACOKINETIC PARAMETERS IN PATIENTS AND CYTOTOXICITY IN-VITRO OF STANDARD AND INVESTIGATIONAL ANTICANCER DRUGS, Anti-cancer drugs, 6(1), 1995, pp. 64-69
CYTOTOXIC ACTIVITY OF TAXOL IN PRIMARY CULTURES OF TUMOR-CELLS FROM PATIENTS IS PARTLY MEDIATED BY CREMOPHOR EL
Authors: NYGREN P CSOKA K JONSSON B FRIDBORG H BERGH J HAGBERG H GLIMELIUS B BRODIN O THOLANDER B KREUGER A LONNERHOLM G JAKOBSSON A OLSEN L KRISTENSEN J LARSSON R
Citation: P. Nygren et al., CYTOTOXIC ACTIVITY OF TAXOL IN PRIMARY CULTURES OF TUMOR-CELLS FROM PATIENTS IS PARTLY MEDIATED BY CREMOPHOR EL, British Journal of Cancer, 71(3), 1995, pp. 478-481
VARIABLE P-GLYCOPROTEIN IMMUNOREACTIVITY UNRELATED TO CYTOTOXIC DRUG-RESISTANCE IN-VITRO OF HUMAN ADRENOCORTICAL CARCINOMA
Authors: BACKLIN C FRIDBORG H JUHLIN C NYGREN P AKERSTROM G RASTAD J LARSSON R
Citation: C. Backlin et al., VARIABLE P-GLYCOPROTEIN IMMUNOREACTIVITY UNRELATED TO CYTOTOXIC DRUG-RESISTANCE IN-VITRO OF HUMAN ADRENOCORTICAL CARCINOMA, International journal of oncology, 5(3), 1994, pp. 565-571
IN-VITRO ACTIVITY OF 2-CHLORODEOXYADENOSINE (CDA) IN PRIMARY CULTURESOF HUMAN HEMATOLOGICAL AND SOLID TUMORS
Authors: LARSSON R FRIDBORG H LILIEMARK J CSOKA K KRISTENSEN J DELATORRE M NYGREN P
Citation: R. Larsson et al., IN-VITRO ACTIVITY OF 2-CHLORODEOXYADENOSINE (CDA) IN PRIMARY CULTURESOF HUMAN HEMATOLOGICAL AND SOLID TUMORS, European journal of cancer, 30A(7), 1994, pp. 1022-1026
INTERACTIONS BETWEEN CLADRIBINE (2-CHLORODEOXYADENOSINE) AND STANDARDANTILEUKEMIC DRUGS IN PRIMARY CULTURES OF HUMAN TUMOR-CELLS FROM PATIENTS WITH ACUTE MYELOCYTIC-LEUKEMIA
Authors: KRISTENSEN J NYGREN P LILIEMARK J FRIDBORG H KILLANDER A SIMONSSON B OBERG G LARSSON R
Citation: J. Kristensen et al., INTERACTIONS BETWEEN CLADRIBINE (2-CHLORODEOXYADENOSINE) AND STANDARDANTILEUKEMIC DRUGS IN PRIMARY CULTURES OF HUMAN TUMOR-CELLS FROM PATIENTS WITH ACUTE MYELOCYTIC-LEUKEMIA, Leukemia, 8(10), 1994, pp. 1712-1717
P-GLYCOPROTEIN EXPRESSION AND ACTIVITY OF RESISTANCE MODIFYING AGENTSIN PRIMARY CULTURES OF HUMAN RENAL AND ADRENOCORTICAL CARCINOMA-CELLS
Authors: FRIDBORG H LARSSON R JUHLIN C RASTAD J AKERSTROM G BACKLIN K NYGREN P
Citation: H. Fridborg et al., P-GLYCOPROTEIN EXPRESSION AND ACTIVITY OF RESISTANCE MODIFYING AGENTSIN PRIMARY CULTURES OF HUMAN RENAL AND ADRENOCORTICAL CARCINOMA-CELLS, Anticancer research, 14(3A), 1994, pp. 1009-1016
DETECTION OF TUMOR-SPECIFIC CYTOTOXIC DRUG ACTIVITY IN-VITRO USING THE FLUOROMETRIC MICROCULTURE CYTOTOXICITY ASSAY AND PRIMARY CULTURES OFTUMOR-CELLS FROM PATIENTS
Authors: NYGREN P FRIDBORG H CSOKA K SUNDSTROM C DELATORRE M KRISTENSEN J BERGH J HAGBERG H GLIMELIUS B RASTAD J THOLANDER B LARSSON R
Citation: P. Nygren et al., DETECTION OF TUMOR-SPECIFIC CYTOTOXIC DRUG ACTIVITY IN-VITRO USING THE FLUOROMETRIC MICROCULTURE CYTOTOXICITY ASSAY AND PRIMARY CULTURES OFTUMOR-CELLS FROM PATIENTS, International journal of cancer, 56(5), 1994, pp. 715-720
ACTIVITY OF CYCLOSPORINES AS RESISTANCE MODIFIERS IN PRIMARY CULTURESOF HUMAN HEMATOLOGICAL AND SOLID TUMORS
Authors: FRIDBORG H JONSSON B NYGREN P CSOKA K NILSSON K OBERG G KRISTENSEN J BERGH J THOLANDER B OLSEN L JAKOBSON A LARSSON R
Citation: H. Fridborg et al., ACTIVITY OF CYCLOSPORINES AS RESISTANCE MODIFIERS IN PRIMARY CULTURESOF HUMAN HEMATOLOGICAL AND SOLID TUMORS, British Journal of Cancer, 70(1), 1994, pp. 11-17
INVITRO TESTING OF CHEMOTHERAPEUTIC DRUG-COMBINATIONS IN ACUTE MYELOCYTIC-LEUKEMIA USING THE FLUOROMETRIC MICROCULTURE CYTOTOXICITY ASSAY (FMCA)
Authors: LARSSON R FRIDBORG H KRISTENSEN J SUNDSTROM C NYGREN P
Citation: R. Larsson et al., INVITRO TESTING OF CHEMOTHERAPEUTIC DRUG-COMBINATIONS IN ACUTE MYELOCYTIC-LEUKEMIA USING THE FLUOROMETRIC MICROCULTURE CYTOTOXICITY ASSAY (FMCA), British Journal of Cancer, 67(5), 1993, pp. 969-974
Risultati: 1-15 |